The global optical disorder drugs market is set for steady growth, driven by the rising prevalence of eye-related conditions and increasing demand for effective treatments. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of nearly 6% over the forecast period of 2022-2028. The market, which generated over USD 40 billion in revenue in...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian